Related Experiment Video
Updated: Jul 15, 2026

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues
Thérese Cronin1, Thierry Léveillard, José-Alain Sahel
1Laboratoire de physiopathologie cellulaire et moleculaire de la retine, unite 592 Inserm-universite Pierre-et-Marie-Curie, France.
Abstract:
Extracellular signaling molecules have been implicated in the progression of Retinal Degeneration (RD). Gene regulatory events linked to the maintenance of retinal structure and function incorporate signaling cascades that may serve as therapeutic targets for some forms of blindness. This review shall focus on the evidence for non-cell-autonomous mechanisms that affect the pattern of degeneration seen in retinal dystrophies, the types of signals that may influence the course of degeneration and finally with the related prospects for retinal-therapies.
Insights
Extracellular signals drive retinal degeneration (RD). Understanding these non-cell-autonomous mechanisms offers new therapeutic targets for blindness caused by retinal dystrophies.
Area of Science:
- Ophthalmology and Molecular Biology
Background:
- Retinal degeneration (RD) involves complex extracellular signaling.
- Gene regulation is crucial for retinal structure and function.
Purpose of the Study:
- Review non-cell-autonomous mechanisms in retinal dystrophies.
- Identify signaling molecules influencing degeneration.
- Explore therapeutic prospects for blindness.
Main Methods:
- Literature review of studies on retinal degeneration.
- Analysis of extracellular signaling pathways.
- Evaluation of gene regulatory events in retinal diseases.
Main Results:
- Non-cell-autonomous mechanisms significantly impact RD patterns.
- Specific signaling molecules modulate disease progression.
- Therapeutic strategies targeting these signals show promise.
Conclusions:
- Extracellular signaling is a key factor in retinal degeneration.
- Targeting these pathways presents viable therapeutic opportunities for retinal dystrophies.
- Further research can advance treatments for blindness.
Related Concept Videos
Diabetic Retinopathy
iPS Cell Differentiation
